Drugs Information:
Teriflunomide
Basic Information
|
||
ID | DDInter1771 | |
Drug Type | small molecule | |
Molecular Formula | C12H9F3N2O2 | |
Molecular Weight | 270.207 | |
CAS Number | 163451-81-8 | |
Description | Teriflunomide is the active metabolite of leflunomide, and it acts as an immunomodulatory agent by inhibiting pyrimidine synthesis. It is marketed under the name Aubagio® and is indicated for the treatment of multiple sclerosis, specifically relapsing forms. The FDA label states an important warning about the risk of hepatoxicity and teratogenicity for patients using teriflunomide. | |
ATC Classification | L04AA31 | |
IUPAC Name | (2Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide | |
InChI | UTNUDOFZCWSZMS-YFHOEESVSA-N | |
Canonical SMILES | C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB Wikipedia ChEMBL ZINC |
Interactions with
Teriflunomide
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|